Yu-Kang Tu
13PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (13)
Sort by Publication Date:
|Apr 13, 2023
Local Consolidative Therapy May Have Prominent Clinical Efficacy in Patients with <i>EGFR</i>-Mutant Advanced Lung Adenocarcinoma Treated with First-Line Afatinib.Ming-Ju Tsai, Jen-Yu Hung, Juei-Yang Ma
|Jan 08, 2023
Different Tyrosine Kinase Inhibitors Used in Treating EGFR-Mutant Pulmonary Adenocarcinoma with Brain Metastasis and Intracranial Intervention Have No Impact on Clinical Outcomes.Chia-Yu Kuo, Ming-Ju Tsai, Jen-Yu Hung
|Oct 10, 2022
Real-world treatment pattern and prognostic factors of stage IV lung squamous cell carcinoma patients.En-Chi Hsu, Kuan-Li Wu, Ying-Ming Tsai
|Sep 14, 2022
Characterization of the Oncogenic Potential of Eukaryotic Initiation Factor 4A1 in Lung Adenocarcinoma via Cell Cycle Regulation and Immune Microenvironment Reprogramming.Kuan-Li Wu, Yung-Chi Huang, Yu-Yuan Wu
|Jun 24, 2022
The Therapeutic Potential of ADAMTS8 in Lung Adenocarcinoma without Targetable Therapy.Hsiao-Chen Lee, Chao-Yuan Chang, Kuan-Li Wu
|Jun 24, 2022
Impact of Smoking Status in Combination Treatment with EGFR Tyrosine Kinase Inhibitors and Anti-Angiogenic Agents in Advanced Non-Small Cell Lung Cancer Harboring Susceptible EGFR Mutations: Systematic Review and Meta-Analysis.Tai-Huang Lee, Hsiao-Ling Chen, Hsiu-Mei Chang
Pageof 3
Frequent Collaborators
11 joint publications
Kuan-Li Wu
7 joint publications
Jen-Yu Hung
6 joint publications
Inn-Wen Chong
5 joint publications
Cheng-Hao Chuang
4 joint publications
Hsiu-Mei Chang
4 joint publications
Ming-Ju Tsai
3 joint publications
Yu-Kang Tu
2 joint publications
Yu-Wei Liu
2 joint publications
Hsiao-Chen Lee
1 joint publications
Meng-Chi Yen
